Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial.

J Bailey, Clifford; L Gross, Jorge; Hennicken, Delphine; Iqbal, Nayyar; A Mansfield, Traci; F List, James

doi:10.1186/1741-7015-11-43

Public

Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial.

Shared by NobleBlocks on Feb 20, 2013 • 12:00 AM UTC

Authors:

Clifford J Bailey

Jorge L Gross

Delphine Hennicken

Abstract

BACKGROUND: Management of type 2 diabetes with metformin often does not provide adequate glycemic control, thereby necessitating add-on treatment. In a 24-week clinical trial, dapagliflozin, an investigational sodium glucose cotransporter 2 inhibitor, improved glycemic control in patients inadequate...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!